Providing new therapies to patients living with unmet needs faster and more efficiently is an industry-wide challenge. A major key to improving the speed cost and quality of drug development is harnessing the insights of the customer – patients themselves. The traditional model of clinical development has looked at drug development through the lens of...
Read moreA new study entitled The Economic Footprint of the Pharmaceutical Industry – Regional breakdown and differentiation between originators and generics, independently conducted by WifOR reveals how the pharmaceutical industry, one of the world’s largest industries, plays a major role in boosting the global economy across regions. The study was commissioned by the IFPMA and aims...
Read moreThe aims of the European Organisation for Research and Treatment of Cancer (EORTC) are to develop, conduct, coordinate, and stimulate translational and clinical research in Europe to improve the management of cancer and related problems by increasing survival but also patient quality of life. Extensive and comprehensive research in this wide field is often beyond...
Read moreTo: Chancellor Angela Merkel, Federal Republic of Germany, President of the 2015 G7 Prime Minister Shinzō Abe, Japan Prime Minister David Cameron, United Kingdom Prime Minister Stephen Harper, Canada President François Hollande, Republic of France President Barack Obama, United States of America Prime Minister Matteo Renzi, Republic of Italy Cc: G7 Foreign Ministers and G7...
Read more